Cocaine

With 2021 now receding in the rear view mirror, we look back at the good, the bad, and the ugly in the arena of drug policy around the world.

Republican lawmakers in Missouri and Ohio roll out marijuana legalization legislation, the New York Times reports that the Syrian government is a major trafficker of the amphetamine captagon, and more.

Mississippians may get a medical marijuana program afterall, the House defense spending bill includes marijuana banking provisions, and more.

Grand Rapids, Michigan, endorses a symbolic psychedelic reform, the House votes to end the crack/powder cocaine sentencing disparity, and more.

California wants to try a form of drug treatment where users are paid not to use, Vancouver activists plan to mark International Overdose Awareness Day with a "safe supply" drug giveaway, and more.

Marijuana legalization bills in Delaware and Rhode Island get delayed, Morocco's parliament has approved the legalization of hemp and medical marijuana, and more.

An Illinois marijuana equity bill heads for a House floor vote, a loosening of medical marijuana regulations during the pandemic may be made permanent in Pennsylvania, the Texas legislature advances bills to reduce penalties for pot concentrates and to study the therapeutic use of psychedelics, and more.

US-Mexico law enforcement cooperation in battling Mexican drug cartels is at a standstill, a Montana marijuana legalization implementation bill is heading for House and Senate floor votes, and more.

A leading neuropsychopharmacologist speaks his minds about drugs.

Here are the biggest world drug policy stories of 2020.